Specializing in portable oxygen concentrators, this company provides respiratory therapy solutions primarily for patients with chronic obstructive pulmonary disease (COPD). Its direct-to-consumer and business-to-business models attract investor attention amid growing demand for home healthcare equipment. Recent financial struggles and competitive pressures have made it a volatile stock in the medical devices space.
1 member of Congress has disclosed 1 trade in Inogen, Inc. (INGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-11-20 | Lamar Smith | buy | $1K – $15K |